NM_001002010.5:c.378T>C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001002010.5(NT5C3A):​c.378T>C​(p.Tyr126Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,609,592 control chromosomes in the GnomAD database, including 395,204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 38911 hom., cov: 32)
Exomes 𝑓: 0.70 ( 356293 hom. )

Consequence

NT5C3A
NM_001002010.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.332
Variant links:
Genes affected
NT5C3A (HGNC:17820): (5'-nucleotidase, cytosolic IIIA) This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. Mutations in this gene are a cause of hemolytic anemia due to uridine 5-prime monophosphate hydrolase deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and pseudogenes of this gene are located on the long arm of chromosomes 3 and 4. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 7-33021334-A-G is Benign according to our data. Variant chr7-33021334-A-G is described in ClinVar as [Benign]. Clinvar id is 440011.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-33021334-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.332 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NT5C3ANM_001002010.5 linkc.378T>C p.Tyr126Tyr synonymous_variant Exon 5 of 9 ENST00000610140.7 NP_001002010.2 Q9H0P0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NT5C3AENST00000610140.7 linkc.378T>C p.Tyr126Tyr synonymous_variant Exon 5 of 9 1 NM_001002010.5 ENSP00000476480.2 X6RM59

Frequencies

GnomAD3 genomes
AF:
0.712
AC:
108174
AN:
151908
Hom.:
38872
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.770
Gnomad AMI
AF:
0.504
Gnomad AMR
AF:
0.728
Gnomad ASJ
AF:
0.560
Gnomad EAS
AF:
0.489
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.703
Gnomad OTH
AF:
0.684
GnomAD3 exomes
AF:
0.683
AC:
171010
AN:
250244
Hom.:
59497
AF XY:
0.676
AC XY:
91411
AN XY:
135318
show subpopulations
Gnomad AFR exome
AF:
0.771
Gnomad AMR exome
AF:
0.773
Gnomad ASJ exome
AF:
0.571
Gnomad EAS exome
AF:
0.476
Gnomad SAS exome
AF:
0.608
Gnomad FIN exome
AF:
0.754
Gnomad NFE exome
AF:
0.694
Gnomad OTH exome
AF:
0.681
GnomAD4 exome
AF:
0.697
AC:
1015392
AN:
1457566
Hom.:
356293
Cov.:
42
AF XY:
0.693
AC XY:
502456
AN XY:
725208
show subpopulations
Gnomad4 AFR exome
AF:
0.776
Gnomad4 AMR exome
AF:
0.768
Gnomad4 ASJ exome
AF:
0.557
Gnomad4 EAS exome
AF:
0.500
Gnomad4 SAS exome
AF:
0.611
Gnomad4 FIN exome
AF:
0.755
Gnomad4 NFE exome
AF:
0.707
Gnomad4 OTH exome
AF:
0.676
GnomAD4 genome
AF:
0.712
AC:
108269
AN:
152026
Hom.:
38911
Cov.:
32
AF XY:
0.713
AC XY:
52957
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.770
Gnomad4 AMR
AF:
0.728
Gnomad4 ASJ
AF:
0.560
Gnomad4 EAS
AF:
0.489
Gnomad4 SAS
AF:
0.605
Gnomad4 FIN
AF:
0.760
Gnomad4 NFE
AF:
0.703
Gnomad4 OTH
AF:
0.679
Alfa
AF:
0.701
Hom.:
22804
Bravo
AF:
0.712
Asia WGS
AF:
0.545
AC:
1889
AN:
3460
EpiCase
AF:
0.679
EpiControl
AF:
0.679

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 12, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.69
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3750117; hg19: chr7-33060946; COSMIC: COSV54237180; COSMIC: COSV54237180; API